Black Rock Inc. Tango Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,987,852 shares of TNGX stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,987,852

Previous 3,861,362 3.28%

Holding current value

$12.4 Million

Previous $30.7 Million 11.6%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$6.66 - $10.15 $842,423 - $1.28 Million	126,490 Added 3.28%	3,987,852 $34.2 Million
Q1 2024 May 10, 2024	SELL	$7.51 - $12.88 $660,234 - $1.13 Million	-87,914 Reduced 2.23%	3,861,362 $30.7 Million
Q4 2023 Feb 13, 2024	BUY	$6.52 - $12.01 $2.55 Million - $4.71 Million	391,757 Added 11.01%	3,949,276 $39.1 Million
Q3 2023 Nov 13, 2023	SELL	$2.93 - $11.26 $190,324 - $731,415	-64,957 Reduced 1.79%	3,557,519 $40.1 Million
Q2 2023 Aug 11, 2023	BUY	$2.67 - $4.7 $223,115 - $392,750	83,564 Added 2.36%	3,622,476 $12 Million
Q1 2023 May 12, 2023	SELL	$3.76 - $8.06 $46,093 - $98,807	-12,259 Reduced 0.35%	3,538,912 $14 Million
Q4 2022 Feb 13, 2023	BUY	$3.41 - $8.29 $2.15 Million - $5.23 Million	630,761 Added 21.6%	3,551,171 $25.7 Million
Q3 2022 Nov 14, 2022	SELL	$3.25 - $5.46 $779,925 - $1.31 Million	-239,977 Reduced 7.59%	2,920,410 $10.6 Million
Q2 2022 Aug 12, 2022	BUY	$3.86 - $8.01 $6.44 Million - $13.4 Million	1,667,201 Added 111.65%	3,160,387 $14.3 Million
Q1 2022 May 12, 2022	BUY	$7.01 - $10.94 $2.39 Million - $3.73 Million	340,746 Added 29.57%	1,493,186 $11.3 Million
Q4 2021 Feb 10, 2022	SELL	$9.55 - $14.29 $2.3 Million - $3.44 Million	-240,728 Reduced 17.28%	1,152,440 $12.6 Million
Q3 2021 Nov 09, 2021	BUY	$9.56 - $17.3 $13.3 Million - $24.1 Million	1,393,168 New	1,393,168 $18 Million

Others Institutions Holding TNGX

# of Institutions

123

Shares Held

91.7M

Call Options Held

3.1K

Put Options Held

1.5K

View Full List

About Tango Therapeutics, Inc.

Ticker TNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 88,067,296
Market Cap $273M
Description
Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...

More about TNGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account